Mesobster选择发行5000万美元可转换票据

2025-09-04 13:34

Mesoblast (OTCPK:MEOBF) entered into convertible note subscription agreements with SurgCenter principals and existing Mesoblast shareholders, Gregory George and William Gueck to issue up to $50M (A$76.8M) unsecured convertible notes.
The funding is available at Mesoblast’s option to repay or reduce the amount owing to its secured lenders under the existing loan agreements and for general working capital purposes.
The company, at its sole discretion, may issue up to $50M in unsecured convertible notes in tranches of $10M.
The maturity date of the convertible notes will be 5 years after the first issuance of notes.
As consideration, the investors collectively will receive a commitment fee of $100,000 and, subject to shareholder approval, of 2M warrants over 2M ordinary shares.

More on Mesoblast